These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18383322)

  • 1. Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults.
    Olson N; O'Meara ES; Jenny NS; Folsom AR; Bovill EG; Furberg CD; Heckbert SR; Psaty BM; Cushman M
    Am J Hematol; 2008 Jul; 83(7):524-7. PubMed ID: 18383322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective study.
    Folsom AR; Lutsey PL; Roetker NS; Ballantyne CM; Hoogeveen RC; Rosamond WD; Cushman M;
    Thromb Res; 2013 Jul; 132(1):44-6. PubMed ID: 23746626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.
    Fitzpatrick AL; Irizarry MC; Cushman M; Jenny NS; Chi GC; Koro C
    Atherosclerosis; 2014 Aug; 235(2):384-91. PubMed ID: 24929287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Lipoprotein-Associated Phospholipase A
    Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
    Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
    Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.
    Nelson TL; Biggs ML; Kizer JR; Cushman M; Hokanson JE; Furberg CD; Mukamal KJ
    J Clin Endocrinol Metab; 2012 May; 97(5):1695-701. PubMed ID: 22399516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A
    Garg PK; Norby FL; Polfus LM; Boerwinkle E; Gibbs RA; Grove ML; Folsom AR; Garimella PS; Matsushita K; Hoogeveen RC; Ballantyne CM
    Atherosclerosis; 2018 Jan; 268():12-18. PubMed ID: 29169030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lipoprotein-associated phospholipase A
    Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
    Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
    Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study.
    van Vark LC; Kardys I; Bleumink GS; Knetsch AM; Deckers JW; Hofman A; Stricker BH; Witteman JC
    Eur Heart J; 2006 Oct; 27(19):2346-52. PubMed ID: 16952920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
    Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
    Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Sarno MJ; Bettencourt R; Wolfert RL; Barrett-Connor E
    J Am Coll Cardiol; 2008 Mar; 51(9):913-9. PubMed ID: 18308160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis.
    Liu J; Wang W; Qi Y; Yong Q; Zhou G; Wang M; Sun J; Liu J; Jia Z; Zhao D
    J Atheroscler Thromb; 2014; 21(6):532-42. PubMed ID: 24492522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
    Suzuki T; Solomon C; Jenny NS; Tracy R; Nelson JJ; Psaty BM; Furberg C; Cushman M
    Circ Heart Fail; 2009 Sep; 2(5):429-36. PubMed ID: 19808373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.
    Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
    Cerebrovasc Dis; 2009; 27(1):42-50. PubMed ID: 19018137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke.
    Lin J; Zheng H; Cucchiara BL; Li J; Zhao X; Liang X; Wang C; Li H; Mullen MT; Johnston SC; Wang Y; Wang Y;
    Neurology; 2015 Nov; 85(18):1585-91. PubMed ID: 26311748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.
    Wang Y; Zhou B; Zhou P; Yao Y; Cui Q; Liu Y; Yang J; Wu S; Zhao X; Zhou Y
    J Cell Mol Med; 2018 Apr; 22(4):2329-2336. PubMed ID: 29424477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 in coronary heart disease: Review and meta-analysis.
    Li D; Zhao L; Yu J; Zhang W; Du R; Liu X; Liu Y; Chen Y; Zeng R; Cao Y; Zeng Z; Zhao Z; Wu J
    Clin Chim Acta; 2017 Feb; 465():22-29. PubMed ID: 27956130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated phospholipase A
    Garg PK; Jorgensen NW; McClelland RL; Jenny NS; Criqui MH; Allison MA; Greenland P; Rosenson RS; Siscovick DS; Cushman M
    Vasc Med; 2017 Feb; 22(1):5-12. PubMed ID: 28215109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.